Idorsia expands its commercialization partnership with Syneos Health for daridorexant in Europe and Canada

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

Germany ,United Kingdom ,Allschwil ,Switzerland General ,Switzerland ,Italy ,Canada ,France ,Spain ,Swiss ,Andrewc Weiss ,Christian Tucat ,Ronnie Speight ,Simon Jose ,Gary Gatyas ,Jean Yves Chatelan ,Michelle Keefe ,Idorsia Ltd ,Head Of Investor Relations Corporate Communications ,Swiss Exchange ,Nasdaq ,Syneos Health Press Media Contact ,Syneos Health ,Syneos Health Investor Relations ,Idorsia Pharmaceuticals Ltd ,Chief Commercial Officer ,Medical Affairs ,Yves Chatelan ,Syneos One ,Health Investor Relations ,Media Contact ,Vice President ,Investor Relations ,Executive Director ,External Communications ,Media Relations ,Corporate Communications ,Pharmaceuticals Ltd ,Business ,Europe ,Globe Newswire ,